Urinary Incontinence

Urinary incontinence (UI) is the involuntary leakage of urine that is objectively demonstrable and a social or hygienic problem. It is one of the most reliably tested topics in gynaecology because the four clinical subtypes — stress, urge, overflow, and mixed — map onto neat, examinable distinctions in mechanism, bedside test, urodynamic finding, and first-line management. Master the type-to-treatment mapping and most NEET PG scenario MCQs become single-step recalls.

Definitions and key concepts

Continence depends on the urethral closure pressure exceeding the intravesical (bladder) pressure at all times except during voluntary voiding. Anything that lowers urethral support/pressure or raises bladder pressure inappropriately causes leakage.

• Continence mechanism: intact urethral sphincter (internal smooth muscle + external rhabdosphincter), adequate urethral support by the pubocervical fascia and levator ani (the "hammock"), and a stable detrusor that stays relaxed during filling.
• Detrusor: the bladder smooth muscle, parasympathetically driven (M3 muscarinic, S2–S4 via pelvic nerve). Contraction = voiding.
• Internal sphincter: sympathetic (α-adrenergic, hypogastric nerve, T10–L2) — maintains closure during filling.
• External sphincter: somatic (pudendal nerve, S2–S4) — voluntary control.

High-yield: Filling/storage = sympathetic (β-relaxes detrusor, α-contracts sphincter) + somatic. Voiding = parasympathetic (M3 detrusor contraction). Mnemonic: "Storage = Sympathetic; Pee = Parasympathetic."

Classification of urinary incontinence

Type	Mechanism	Classic trigger	Leak volume	Post-void residual (PVR)
Stress (SUI)	Urethral hypermobility / intrinsic sphincter deficiency; ↑abdominal pressure overcomes urethral pressure	Cough, sneeze, laugh, lifting	Small spurts	Normal
Urge (OAB)	Detrusor overactivity — involuntary detrusor contractions during filling	Sudden urgency, "key-in-lock", running water	Large, complete	Normal
Mixed	Both SUI + urge features	Both	Variable	Normal
Overflow	Chronic retention from outlet obstruction or atonic/areflexic detrusor; bladder overfills and dribbles	Continuous dribbling, incomplete emptying	Small/dribble continuous	High (>200 mL)
Functional	Continence mechanism intact; cognitive/mobility barrier reaches toilet too late	Dementia, arthritis, restraints	Variable	Normal
Continuous (fistula/ectopic ureter)	Anatomical bypass of sphincter	Constant wetness day & night	Continuous	Normal

High-yield: Continuous, painless dribbling of urine after pelvic surgery / obstructed labour / hysterectomy = vesicovaginal fistula until proven otherwise. An ectopic ureter opening below the sphincter causes constant dribbling plus normal voiding in a young girl.

Etiology and risk factors

Stress incontinence is fundamentally a problem of loss of urethral support (urethral hypermobility) or intrinsic sphincter deficiency (ISD).

• Multiparity, vaginal delivery (pudendal nerve and pelvic floor injury) — the single biggest gynaecological risk factor.
• Ageing, oestrogen deficiency / menopause (urogenital atrophy).
• Obesity, chronic cough (COPD), chronic constipation, heavy lifting (chronically ↑ intra-abdominal pressure).
• Prior pelvic surgery, prolapse, connective tissue disorders.
• ISD specifically follows radiotherapy, multiple anti-incontinence surgeries, or neurological injury → fixed, poorly coapting urethra.

Urge incontinence / overactive bladder (OAB) arises from detrusor overactivity, which may be:

• Idiopathic (most common).
• Neurogenic — stroke, Parkinson's disease, multiple sclerosis, spinal cord lesions (then termed detrusor hyperreflexia).
• Local irritation — UTI, bladder stone, carcinoma in situ, interstitial cystitis.

Overflow incontinence results from:

• Outlet obstruction — pelvic mass, large prolapse (cystocele kinking urethra), post-anti-incontinence-surgery over-correction, in men BPH.
• Detrusor underactivity / atonic bladder — diabetic autonomic neuropathy, spinal lesions (cauda equina), anticholinergic drugs, post-operative.

Clinical features and history

A focused history usually classifies the type before any test:

1. "Do you leak when you cough, sneeze or laugh?" → SUI.
2. "Do you get a sudden strong urge and leak before reaching the toilet?" → urge.
3. "Do you feel your bladder never empties / dribble constantly?" → overflow.
4. "Are you constantly wet, day and night, with no warning?" → fistula / ectopic ureter.

A frequency-volume chart (bladder diary) over 3 days documenting fluid intake, voided volumes, leak episodes, and pad use is a cheap, high-yield tool. Quantify with pad tests (1-hour or 24-hour). Use validated symptom questionnaires for severity.

Examination and bedside tests

• General: mobility, cognition, neurological screen (S2–S4 dermatomes, anal tone, bulbocavernosus reflex).
• Pelvic: atrophic vaginitis, prolapse (cystocele/rectocele), pelvic mass.
• Stress test (cough/Bonney): ask patient with comfortably full bladder to cough — immediate leak coincident with cough = SUI; delayed leak after a pause suggests cough-induced detrusor overactivity (urge).
• Q-tip test: a lubricated cotton-tipped applicator is placed in the urethra to the urethrovesical junction; the patient strains. Deflection > 30° from horizontal = urethral hypermobility, supporting SUI.

High-yield: Q-tip test angle > 30° on straining = urethral hypermobility (the hallmark of supportive SUI). It does NOT diagnose ISD.

High-yield: The Bonney / Marshall test (elevating the urethrovesical junction with two fingers and re-coughing to stop leak) was historically used to predict surgical success — now considered unreliable, but still a recall item.

Investigations

Baseline for everyone: urinalysis ± culture (exclude UTI), post-void residual (PVR) by catheter or bladder ultrasound, and a bladder diary.

Investigation	Purpose	Key value
Urinalysis/culture	Exclude infection, haematuria	—
Post-void residual	Distinguish overflow	PVR > 200 mL = significant retention
Bladder diary	Quantify frequency, volume, leaks	3-day chart
Urodynamics (multichannel cystometry)	Define detrusor behaviour & pressures	See below
Cystoscopy	Fistula, tumour, stone, interstitial cystitis	—
Three-swab (tampon) test	Localise/confirm vesicovaginal fistula	Methylene blue dye

Urodynamic study (UDS) is the gold-standard/investigation of choice when the diagnosis is unclear, before surgery, or when conservative therapy fails. Components:

• Uroflowmetry — voiding flow rate.
• Cystometry (filling) — detects involuntary detrusor contractions; in detrusor overactivity you see a rise in detrusor pressure during filling with urgency.
• Valsalva leak point pressure (VLPP / abdominal LPP) — pressure at which leakage occurs on straining; VLPP < 60 cm H₂O suggests intrinsic sphincter deficiency (ISD); > 90 cm H₂O suggests hypermobility-type SUI.
• Pressure-flow study — diagnoses outlet obstruction vs detrusor underactivity in overflow.

High-yield: VLPP < 60 cm H₂O = intrinsic sphincter deficiency; this guides choice toward a tension-free sling / bulking agent rather than simple support. Genuine stress incontinence (urodynamic SUI) = leakage with raised abdominal pressure in the absence of a detrusor contraction.

Three-swab test for suspected fistula: place three swabs in the vagina, instil methylene blue into the bladder. Top swab blue = ureterovaginal fistula (urine bypasses bladder dye? — actually a clear top swab wet with urine suggests ureterovaginal; dye on middle/lower swab = vesicovaginal). Practically: dye-stained lower swabs = vesicovaginal fistula; wet-but-clear upper swab = ureterovaginal fistula.

Management

General principles and the stepwise approach

Conservative/behavioural first → pharmacotherapy → surgery.

Lifestyle/behavioural measures (first line for all): weight loss, reduce caffeine/alcohol, treat constipation and chronic cough, timed/scheduled voiding, fluid management, treat atrophic vaginitis with topical oestrogen.

Stress urinary incontinence (SUI)

Step 1 → Pelvic floor muscle training (PFMT / Kegel exercises) — the first-line, evidence-based conservative treatment; supervised programmes for ≥ 3 months. Adjuncts: vaginal cones, biofeedback, electrical stimulation, pessary / continence ring.

Step 2 → Surgery (definitive):

• Mid-urethral sling — Tension-free Vaginal Tape (TVT, retropubic) or Trans-Obturator Tape (TOT/TVT-O) — the current surgical gold standard for SUI. TOT carries lower risk of bladder/bowel/vessel injury than retropubic TVT but slightly higher groin pain.
• Burch colposuspension — open/laparoscopic; suspends the paravaginal fascia to the iliopectineal (Cooper's) ligament; durable, used when abdominal surgery is concurrent.
• Marshall-Marchetti-Krantz (MMK) — older retropubic suspension to the pubic symphysis periosteum; risk of osteitis pubis (eponym recall).
• Pubovaginal autologous fascial sling — for recurrent SUI or ISD.
• Periurethral bulking agents (e.g., macroplastique) — for ISD or poor surgical candidates; less durable.

High-yield: First-line for SUI = pelvic floor muscle training (Kegel exercises). Surgical gold standard = mid-urethral sling (TVT/TOT). There is no effective pharmacotherapy for SUI in routine Indian practice (duloxetine is only modestly effective and not first-line).

Urge incontinence / overactive bladder (OAB)

Step 1 → Bladder training (scheduled voiding with progressively increasing intervals) + lifestyle measures + PFMT. First line.

Step 2 → Pharmacotherapy:

• Antimuscarinics / anticholinergics — drug of choice: oxybutynin, tolterodine, solifenacin, darifenacin, trospium. They block M3 detrusor contraction. Side effects (anticholinergic): dry mouth, constipation, blurred vision, urinary retention; contraindicated in narrow-angle glaucoma. Caution in elderly (cognitive impairment).
• β3-adrenergic agonist — mirabegron: relaxes detrusor during storage; useful when anticholinergics are contraindicated/poorly tolerated.

Step 3 → Refractory OAB: intravesical botulinum toxin A injection, sacral neuromodulation, or posterior tibial nerve stimulation.

High-yield: First-line drug for urge incontinence/OAB = antimuscarinic (oxybutynin/solifenacin); avoid in narrow-angle glaucoma. Mirabegron (β3 agonist) is the alternative.

Mixed incontinence

Treat the predominant component first. If urge predominates → bladder training + antimuscarinics. If stress predominates → PFMT then sling. Surgery for SUI may unmask or worsen urge symptoms — counsel accordingly.

Overflow incontinence

Relieve obstruction or decompress the bladder. Treat the cause: clean intermittent self-catheterisation (CISC) for atonic/neurogenic bladder, relieve prolapse/obstruction, cholinergics (bethanechol) are largely ineffective and rarely used. Treat underlying diabetes/neuropathy.

Fistula

Vesicovaginal fistula — small fresh fistulae may close with continuous catheter drainage for 4–6 weeks; established fistulae need surgical repair. Classic timing: repair after 3 months (allow inflammation to settle) for obstetric fistula, though early repair within 1–2 weeks is acceptable for clean surgical fistulae. Routes: vaginal (Latzko) or abdominal.

Complications

• Of incontinence itself: recurrent UTI, perineal dermatitis/excoriation, falls and fractures (rushing to toilet), social isolation, depression, sexual dysfunction.
• Of overflow/chronic retention: hydronephrosis, recurrent UTI, renal impairment.
• Of surgery (sling): bladder/urethral injury, voiding dysfunction/retention, de novo urgency, mesh erosion/extrusion, dyspareunia, groin pain (TOT), vascular/bowel injury (retropubic TVT).

Key differentials

• SUI vs urge — the single most tested distinction: trigger (cough vs urgency), leak volume (small vs large), and stress-test timing (immediate vs delayed).
• Overflow — always check PVR; high PVR with dribbling clinches it.
• Vesicovaginal fistula vs incontinence — continuous painless wetness day and night post-surgery/obstructed labour → three-swab/dye test, cystoscopy.
• Ectopic ureter — young girl, normal voiding + constant dribbling.
• UTI / urethritis — irritative symptoms mimicking OAB; always exclude with urinalysis first.

Recently asked / exam angle

• Scenario: multiparous woman leaks urine on coughing, Q-tip deflects > 30°, normal PVR → stress incontinence; first step = pelvic floor exercises, definitive surgery = TVT/TOT sling.
• VLPP < 60 cm H₂O → intrinsic sphincter deficiency (match-the-value MCQ).
• Investigation of choice for unclear/pre-surgical incontinence → urodynamic study (cystometry).
• Drug of choice for OAB → anticholinergic (oxybutynin/solifenacin); contraindicated in glaucoma; alternative = mirabegron.
• Continuous dribbling after hysterectomy / obstructed labour → vesicovaginal fistula; confirm with three-swab (methylene blue) test.
• Eponym recall: Burch colposuspension → Cooper's (iliopectineal) ligament; MMK → osteitis pubis; Latzko → vaginal VVF repair.
• Q-tip test interprets urethral hypermobility, not sphincter function — common distractor.
• Mechanism MCQ: detrusor = M3 muscarinic (parasympathetic); storage = sympathetic α/β.

Rapid revision

1. SUI = leak on cough/sneeze; urge = sudden urgency; overflow = dribbling with high PVR; mixed = both.
2. Storage = sympathetic; voiding = parasympathetic (M3 detrusor).
3. Q-tip deflection > 30° = urethral hypermobility (supports SUI).
4. PVR > 200 mL suggests overflow / retention.
5. Urodynamics (cystometry) = investigation of choice before surgery / when unclear.
6. VLPP < 60 cm H₂O = intrinsic sphincter deficiency.
7. SUI first line = Kegel/pelvic floor muscle training; surgical gold standard = mid-urethral sling (TVT/TOT).
8. No reliable drug for SUI; duloxetine only modestly effective.
9. OAB/urge first line = bladder training, then antimuscarinics (oxybutynin/solifenacin), then mirabegron / botulinum toxin / neuromodulation.
10. Antimuscarinics are contraindicated in narrow-angle glaucoma; cause dry mouth & constipation.
11. Continuous painless wetness day & night = vesicovaginal fistula / ectopic ureter; confirm with three-swab dye test.
12. TOT has lower visceral injury risk than retropubic TVT; mesh erosion is a key sling complication.